Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
58 Results for "
Compound 31
" in MedChemExpress (MCE) Product Catalog:
Products (58)
58 Results for "Compound 31" in MCE Product Catalog:
Cat. No.: HY-157206
CAS No.: 1313602-77-5
ICMT-IN-55 (compound 31) is an ICMT inhibitor with IC50=90 nM .
Cat. No.: HY-149761
Target:
Research Areas:
GSK023 (compound 31) is a selective chemical probe targeting the BET BD1 domain .
Cat. No.: HY-150974
CAS No.: 2883232-34-4
Target:
Research Areas:
ROS1-IN-1 (Compound 31) is a potent and selective ROS1 kinase inhibitor with an IC50 of 0.097 μM .
Cat. No.: HY-168840
Target:
Research Areas:
Insecticidal agent 17 (compound 31) is an insecticidal agent against Plutella xylostella Linnaeus with an LC50 value of 0.759 mg/mL .
Cat. No.: HY-161154
CAS No.: 2170996-03-7
HDAC3-IN-3 (compound 31) is a potent HDAC3 inhibitor. HDAC3-IN-3 has the potential for the research of cancer .
Cat. No.: HY-163088
CAS No.: 1269363-88-3
Target:
Research Areas:
CHIKV-IN-4 (compound 31b) is a potent and selective CHIKV inhibitor. CHIKV-IN-4 inhibits the Chikungunya virus with the EC50 value of 0.6 μM .
Cat. No.: HY-164138
CAS No.: 948581-46-2
17β-HSD5 inhibitor 3 (Compound 31) is an orally active inhibitor for 17β-HSD5 with an IC50 of 69 nM .
Cat. No.: HY-176505
CAS No.: 1283095-64-6
Target:
Research Areas:
NOP antagonist 1 (Compound (-)-31) is a nociceptin opioid peptide (NOP) antagonist with a Kb of 8.65 nM. NOP antagonist 1 can be used for neuropsychiatric disorders research .
Cat. No.: HY-169421
Target:
Research Areas:
Nav1.7-IN-18 (Compound 31) is a Nav1.7 inhibitor with a Ki value of 4.9 nM and an IC50 of 13 nM, showing analgesic effects in transgenic mice with inherited erythromelalgia (IEM) .
Cat. No.: HY-179093
CAS No.: 2540501-85-5
Target:
Research Areas:
KCNT1-IN-3 (Compound 31) is a KCNT1 inhibitor with an IC50 value of 30 nM against the wild-type human KCNT1. KCNT1-IN-3 can be used in the research of epilepsy .
Cat. No.: HY-163194
Target:
Research Areas:
Cbl-b-IN-16 (compound 31) is an orally active Cbl-b inhibtor with IC50 of 30 nM and induces IL-2 production in Hu-T-cells with EC50 of 230 nM. Cbl-b-IN-16 exhibits antitumor activity .
Cat. No.: HY-148067A
Target:
Research Areas:
XMT-1519 conjugate-1 TFA (compound 31) is part of the drug-linker conjugate for ADC and can be conjugated with the HER-2 monoclonal antibody Calotatug (XMT-1519) (HY-P990909) for the synthesis of ADC .
Cat. No.: HY-149736
CAS No.: 3032416-36-4
Target:
Research Areas:
ATP Synthesis-IN-3 (compound 31) is an ATP hydrolysis inhibitor with protective effects during myocardial ischemia. ATP Synthesis-IN-3 can increase the ATP content of ischemic cardiomyocytes, increase the phosphorylation of PKA and phospholamban, and inhibit ischemia-induced apoptosis .
Cat. No.: HY-154994
CAS No.: 2891469-99-9
Target:
Research Areas:
JAK-IN-30 (compound 31) is a water-soluble JAK inhibitor with IC50 values of 2, 15, 18 and 2 nM for JAK2, JAK1, JAK3 and TYK2, respectively. JAK-IN-30 has research potential for dry eye disease (DED) .
Cat. No.: HY-N9477
CAS No.: 25613-12-1
Synonyms: Betulin-28-oxime
Target:
Cat. No.: HY-W354369
CAS No.: 50264-63-6
Research Areas:
1-(4-Fluorobenzyl)-1H-indazole-3-carboxylic acid (Compound 31) is a metabolite of AB-FUBINACA. 1-(4-Fluorobenzyl)-1H-indazole-3-carboxylic acid is a MRGPRX4 antagonist (IC50: >2.5 μM) .
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
